BAL PHARMA
|
The Current P/S Ratio of BAL PHARMA is 0.33.
| Share Price | ₹64.0 | Apr 02,2026 |
| Market Cap | ₹101.8 Cr | |
| Sales-TTM | ₹309.5 Cr | TTM-Consolidated Results |
| Price/Sales | 0.33x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹101.8 Cr] as on Apr 02,2026
(/) Sales [ ₹309.5 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 0.33x ]
Thus, for BAL PHARMA , the investors are currently willing to pay '0.33 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAL PHARMA !
The chart below summarizes the trend in P/S Ratio of BAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of BAL PHARMA
PS Ratio Performance Analysis for BAL PHARMA
- BAL PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.42x.
- BAL PHARMA 's operated at median p/e ratio of 0.43x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAL PHARMA 's p/e ratio peaked in Mar2022 at 0.57x.
- BAL PHARMA 's p/e ratio hit its five-year low in Mar2021 of 0.32x.
How does BAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAL PHARMA | 309.5 | 0.33 | 101.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.16 | 406,603.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.08 | 155,485.0 |
| CIPLA LTD | 28,351.1 | 3.40 | 96,400.8 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.60 | 135,009.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.93 | 101,628.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.93 | 82,460.4 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.33 | 86,963.8 |
| LUPIN LTD | 26,150.5 | 3.98 | 104,091.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.34 | 77,592.2 |
| ABBOTT INDIA LTD | 6,824.1 | 8.18 | 55,833.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAL PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.33x |
| Max industry PS | 15.08x |
| Median industry PS | 3.98x |
| Average industry PS | 5.75x |
You may also like the below Video Courses